Dalbergin
Dalbergin exhibits similar bone conserving effect against bone-loss as estradiol treatment, it as a therapeutic candidate against postmenopausal osteoporosis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
268.26
Molecular Formula
C16H12O4
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
482-83-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items